COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,026 Articles (22,627 medRxiv, 8,399 bioRxiv)

Most recent first Previous |  Page 2965: Articles 29641-29650  | Next

On the interactions of the receptor-binding domain of SARS-CoV-1 and SARS-CoV-2 spike proteins with monoclonal antibodies and the receptor ACE2
Correa Giron, C., Laaksonen, A., Barroso da Silva, F. L.
10.1101/2020.04.05.026377 — Posted: 2020-04-10 Discussion: Onsite
Rapid in silico design of antibodies targeting SARS-CoV-2 using machine learning and supercomputing
Desautels, T., Zemla, A., Lau, E., Franco, M., Faissol, D.
10.1101/2020.04.03.024885 — Posted: 2020-04-10
Optimization of SARS-CoV-2 detection by RT-QPCR without RNA extraction
Merindol, N., Pepin, G., Marchand, C., Rheault, M., Peterson, C., Poirier, A., Germain, H., Danylo, A.
10.1101/2020.04.06.028902 — Posted: 2020-04-10 Discussion: Onsite
BioLaboro: A bioinformatics system for detecting molecular assay signature erosion and designing new assays in response to emerging and reemerging pathogens
Holland, M., Negron, D., Mitchell, S., Dellinger, N., Ivancich, M., Barrus, T., Thomas, S., Jennings, K. W., Goodwin, B. G., Sozhamannan, S.
10.1101/2020.04.08.031963 — Posted: 2020-04-10 Discussion: Onsite | Offsite
Understanding the B and T cells epitopes of spike protein of severe respiratory syndrome coronavirus-2: A computational way to predict the immunogens
Vashi, Y., Jagrit, V., Kumar, S.
10.1101/2020.04.08.013516 — Posted: 2020-04-10
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) envelope (E) protein harbors a conserved BH3-like motif
Navratil, V., Lionnard, L., Longhi, S., Combet, C., Aouacheria, A.
10.1101/2020.04.09.033522 — Posted: 2020-04-10
Robust neutralization assay based on SARS-CoV-2 S-bearing vesicular stomatitis virus (VSV) pseudovirus and ACE2-overexpressed BHK21 cells
Xiong, H., Wu, Y., Cao, J., Yang, R., Ma, J., Qiao, X., Yao, X., Zhang, B., Zhang, Y., Hou, W., Shi, Y., Xu, J., Zhang, L., Wang, S., Fu, B., Yang, T., Ge, S., Zhang, J., Yuan, Q., Huang, B., Li, Z., Zhang, T., Xia, N.
10.1101/2020.04.08.026948 — Posted: 2020-04-09
Vulnerabilities of the SARS-CoV-2 virus to proteotoxicity -- opportunity for repurposed chemotherapy of COVID-19 infection
Al-Motawa, M., Abbas, H., Wijten, P., de la Fuente, A., Xue, M., Rabbani, N., Thornalley, P.
10.1101/2020.04.07.029488 — Posted: 2020-04-09
Characterizing geographical and temporal dynamics of novel coronavirus SARS-CoV-2 using informative subtype markers
Zhao, Z., Sokhansanj, B. A., Rosen, G.
10.1101/2020.04.07.030759 — Posted: 2020-04-09 Discussion: Onsite
Prediction of SARS-CoV interaction with host proteins during lung aging reveals a potential role for TRIB3 in COVID-19.
de Moraes, D., Paiva, B. V. B., Cury, S. S., Araujo, J. P., Mori, M. A. d. S., Carvalho, R. F.
10.1101/2020.04.07.030767 — Posted: 2020-04-09

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).